Dihydropyrimidine Dehydrogenase Deficiency: To Screen or Not to Screen?


Journal

Journal of the advanced practitioner in oncology
ISSN: 2150-0878
Titre abrégé: J Adv Pract Oncol
Pays: United States
ID NLM: 101550346

Informations de publication

Date de publication:
Historique:
entrez: 5 2 2021
pubmed: 6 2 2021
medline: 6 2 2021
Statut: ppublish

Résumé

5-fluorouracil (5-FU) and its prodrug capecitabine are frequently prescribed in oncology. While usually well tolerated, toxicity can be severe, and even life-threatening. A dihydropyrimidine dehydrogenase (DPD) deficiency can cause severe toxicity. Current testing for DPD deficiency does not meet the criteria for a routine screening test prior to 5-FU therapy. A case study of a fatality secondary to capecitabine toxicity is reviewed and literature is examined regarding general screening for DPD deficiency.

Identifiants

pubmed: 33542850
doi: 10.6004/jadpro.2020.11.1.4
pii: 2020.11.1.4
pmc: PMC7517765
doi:

Types de publication

Journal Article

Langues

eng

Pagination

68-73

Informations de copyright

© 2020 Harborside™.

Déclaration de conflit d'intérêts

The author has no conflicts of interest to disclose.

Références

Oncology (Williston Park). 1998 Oct;12(10 Suppl 7):13-8
pubmed: 9830619
Int J Cancer. 2019 May 1;144(9):2347-2354
pubmed: 30485432
Cancer Invest. 2006 Mar;24(2):215-7
pubmed: 16537192
J Clin Invest. 1996 Aug 1;98(3):610-5
pubmed: 8698850
Semin Oncol. 2017 Feb;44(1):13-23
pubmed: 28395758
N Engl J Med. 2005 Feb 3;352(5):476-87
pubmed: 15689586
Clin Cancer Res. 2005 Aug 15;11(16):5886-92
pubmed: 16115930
J Clin Oncol. 2003 Aug 1;21(15):2896-903
pubmed: 12885807
AJR Am J Roentgenol. 2001 Jun;176(6):1357-62
pubmed: 11373191
Clin Cancer Res. 1999 Oct;5(10):2672-3
pubmed: 10537327
Nat Rev Cancer. 2003 May;3(5):330-8
pubmed: 12724731
Ther Adv Med Oncol. 2012 Jul;4(4):167-72
pubmed: 22754590
J Med Case Rep. 2019 Mar 22;13(1):76
pubmed: 30898145
Hum Genet. 1999 Jan;104(1):1-9
pubmed: 10071185
Clin Pharmacol Ther. 2006 Oct;80(4):384-95
pubmed: 17015056
Clin Cancer Res. 2000 Dec;6(12):4705-12
pubmed: 11156223
Semin Oncol. 2017 Apr;44(2):159-160
pubmed: 28923215
Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1257-60
pubmed: 17065102
Ann Oncol. 2016 Aug;27(8):1386-422
pubmed: 27380959

Auteurs

Wendy H Vogel (WH)

Wellmont Cancer Institute, Kingsport, Tennessee.

Ahmed Minhas (A)

East Tennessee State University, Johnson City, Tennessee.

Steven Baumrucker (S)

Wellmont Cancer Institute, Kingsport, Tennessee.

Classifications MeSH